GRI Bio, Inc. (GRI)
1.93
+0.09
(+4.89%)
USD |
NASDAQ |
Sep 18, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 20:00
GRI Bio Total Liabilities (Quarterly) : 1.10M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.10M |
| March 31, 2026 | 0.794M |
| December 31, 2025 | 2.658M |
| September 30, 2025 | 2.789M |
| June 30, 2025 | 2.353M |
| March 31, 2025 | 2.837M |
| December 31, 2024 | 1.707M |
| September 30, 2024 | 1.799M |
| June 30, 2024 | 2.312M |
| March 31, 2024 | 1.789M |
| December 31, 2023 | 2.697M |
| September 30, 2023 | 2.177M |
| June 30, 2023 | 1.604M |
| March 31, 2023 | 2.066M |
| Date | Value |
|---|---|
| December 31, 2022 | 2.008M |
| September 30, 2022 | 2.11M |
| June 30, 2022 | 4.341M |
| March 31, 2022 | 2.584M |
| December 31, 2021 | 2.517M |
| September 30, 2021 | 1.411M |
| June 30, 2021 | 1.794M |
| March 31, 2021 | 2.573M |
| December 31, 2020 | 2.409M |
| September 30, 2020 | 1.631M |
| June 30, 2020 | 1.466M |
| March 31, 2020 | |
| December 31, 2019 | 1.062M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.38M |
| Shareholders Equity (Quarterly) | 10.28M |
| Debt to Equity Ratio | 0.0043 |
| Current Ratio | 10.30 |
| Net Debt Paydown Yield | 0.33% |